Propranolol Hydrochloride NDC 0121-0908

NDC codes

FDA NDC Directory

Product NDC (as listed)0121-0908Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00121-0908Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0121-0908-40	00121090840	4 TRAY in 1 CASE (0121-0908-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-0908-05)Marketed from Sep 3, 2021

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Propranolol Hydrochloride
Generic name (nonproprietary): propranolol hydrochloride
Active ingredients: Propranolol hydrochloride — 20 mg/5mL
Dosage form: Solution
Route: Oral
Labeler: Pharmaceutical Associates, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 070979
Marketing start: Sep 3, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 0121-0908_e20b8c76-152c-9fee-e053-2a95a90aa52dSPL ID e20b8c76-152c-9fee-e053-2a95a90aa52dSPL set ID ec5c919b-05d1-45d2-a6e4-ac4ae1101dbbRxCUI 856724UNII F8A3652H1V
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400121090840 followed by a unit qualifier and the quantity

Package 00121-0908-40. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 22, 2022.

Indications (excerpt from the label)

INDICATIONS AND USAGE Hypertension Propranolol hydrochloride is indicated in the management of hypertension. It may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. Propranolol is not indicated in the management of hypertensive emergencies. Angina Pectoris Due to Coronary Atherosclerosis Propranolol hydrochloride is indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. Atrial Fibrillation Propranolol hydrochloride is indicated to control ventricular rate in patients with atrial fibrillation and a rapid ventricular response. Myocardial Infarction Propranolol hydrochloride is indicated …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 070979

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 070979
Product	Strength	Form · route	Labeler	Product NDC
Propranolol Hydrochloride	Propranolol hydrochloride 20 mg/5mL	SolutionOral	ATLANTIC BIOLOGICALS CORP.	17856-3728
Propranolol Hydrochloride	Propranolol hydrochloride 20 mg/5mL	SolutionOral	ATLANTIC BIOLOGICALS CORP.	17856-8728